News

The discovery of athletes developing myocarditis after battling a COVID-19 infection previously forced several professional and collegiate sports leagues to cancel their major events and seasons. But latest scientific data on the pathogenesis of the coronavirus disease has shed light on how the incidence of heart inflammation among athletes was lower than first thought.  New
0 Comments
PHOENIX — The addition of pembrolizumab (Keytruda) to chemotherapy, with or without bevacizumab (Avastin), in women with persistent, recurrent, or metastatic cervical cancer was linked with better quality of life (QoL), a researcher reported. Patient-reported outcomes (PRO) from the KEYNOTE-826 trial showed that changes from baseline in QLQ-C30 global health status (GHS)/QoL scores — a
0 Comments
The FDA tonight approved a combination nivolumab/relatlimab-rmbw immune checkpoint inhibitor (Opdualag) for unresectable or metastatic melanoma in adults and children 12 years or older, according to the drug’s manufacturer, Bristol-Myers Squibb.  Approval was based on the company’s RELATIVITY-047 trial, which found a median progression-free survival (PFS) of 10.1 months among 355 patients randomly assigned to
0 Comments
A study released by the Centers for Disease Control and Prevention found that the Omicron variant of COVID-19 led to an increased rate of hospitalization in children below the age of 4, which was five times higher than the spread of the Delta variant, according to WebMD.  “COVID-19 can cause severe illness in infants and children,” the CDC said, adding that “COVID-19–associated
0 Comments
A novel open-label, phase II trial recently published in the Journal of Clinical Oncology evaluated the safety and efficacy of balstilimab co-administered with zalifrelimab as second-line treatment for 155 patients with recurrent and/or metastatic cervical cancer who had relapsed after prior platinum-based therapy. In this exclusive MedPage Today interview, Robert DeBernardo, MD, section head of
0 Comments
New data released by Biogen this week show that long-term treatment with aducanumab (Aduhelm) continues to reduce the underlying pathologies of Alzheimer’s disease (AD) after more than 2 years of treatment. Patients receiving aducanumab in the long-term extension phase of two phase 3 trials (ENGAGE and EMERGE) continued to experience significant reductions in amyloid beta
0 Comments
It may feel like a long time ago, but it’s only nine months since the UK was in the grips of the “pingdemic”. Back in the summer of 2021, lifting COVID restrictions saw the country’s contact-tracing apps – the NHS COVID-19 app in England and Wales, the StopCOVID NI app in Northern Ireland, and the
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. A new surge in COVID-19 cases across Western Europe has led U.S. health officials to consider whether another pandemic wave will arrive soon, even as states and cities continue to lift restrictions amid low case numbers. Infectious disease experts are watching
0 Comments
In patients with osteoarthritis (OA) of the knee, intra-articular injections of steroids did not increase rates of either disease progression or subsequent knee replacement surgery, researchers said. Among more than 560 OA patients in a long-running French cohort, 6.0% of those receiving steroid injections underwent knee replacement within 5 years, compared with 6.4% of patients
0 Comments
A population-based developmental surveillance program showed high diagnostic accuracy in identifying autism in a community-based sample of infants, toddlers, and preschoolers, according to new data published online in JAMA Network Open. Researchers, led by Josephine Barbaro, PhD, of Olga Tennison Autism Research Centre at La Trobe University, Bundoora, Australia, said their findings indicate the benefit of
0 Comments
Depression, anxiety, and other mental health issues could be the most intriguing long-term effects of severe COVID-19. A new study found that bedridden patients were at high risk for these conditions that could linger for years after their bout with SARS-CoV-2. COVID-19 And Mental Health  In a study published in The Lancet Public Health journal
0 Comments
Among patients with multiple sclerosis (MS) or neuromyelitis optica spectrum disorders (NMOSD) receiving ocrelizumab or rituximab, B cell depletion appears to last well past the 6-month dosing regimen typically used with these drugs. The results, drawn from a retrospective analysis, provide support for clinical trials to rest longer re-infusion intervals. Dr Mahmoud AbdelRazek The study appeared online Jan.
0 Comments
Use of advanced preoperative 3D planning for pediatric liver transplant patients receiving larger grafts was associated with lower risk of postoperative complications, a small retrospective study in Taiwan found. Kids receiving living-donor livers that were large-for-size — graft-to-recipient weight ratio (GRWR) ≥4% — had a significantly lower risk for postoperative complications in the 3D era
0 Comments
A new expert commentary from the American Gastroenterological Association focuses on noninvasive screening options for colorectal cancer (CRC), as well as approaches to ensure quality in noninvasive screening programs. The commentary was published in Gastroenterology. The American Cancer Society reported in its Cancer Facts & Figures 2021 report that lifetime risk of CRC in the United States is 4%,
0 Comments
The US Food and Drug Administration (FDA) has issued a warning about the off-label use of the Renuvion/J-Plasma device for dermal resurfacing and skin contraction procedures. The device is cleared by the FDA for “general use of cutting, coagulation, and ablation of soft tissue during open and laparoscopic surgical procedures” but “has not been determined
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. It’s now known that tinnitus may be an unexpected side effect of SARS-CoV-2 vaccination, and there is an urgent need to understand the precise mechanisms and best treatment for vaccine-associated tinnitus, researchers say. As of mid-September 2021, 12,247 cases of tinnitus,
0 Comments